Skip to content Skip to navigation

Medication

Total transformation: Phoenix House will dramatically move beyond TC roots

May 23, 2017  |  Gary A. Enos, Editor
article
New Phoenix Life Centers in New York City this summer will signal a major clinical shift for one of the nation's most prominent nonprofit addiction treatment organizations.

Addiction leaders react harshly to HHS secretary's medication comments

May 15, 2017  |  Gary A. Enos, Editor
news
Newspaper comments from Health and Human Services (HHS) Secretary Tom Price that seemed to question the legitimacy of methadone and buprenorphine generated a strong rebuke from addiction specialists.

Buprenorphine film product approved for expanded indication

May 4, 2017  |  Gary A. Enos, Editor
news
The Food and Drug Administration (FDA) has approved a revised indication for Bunavail to include induction to opioid dependence treatment.

Oxytocin a potential treatment for addiction and comorbid mood disorders

April 21, 2017  |  Tom Valentino, Senior Editor
article
A research review published in the British Journal of Pharmacology suggests the neuropeptide oxytocin, administered as an intranasal spray, could be effective in the treatment of opioid addiction and comorbid mood disorders.

Rx Summit: Unlikely political duo teams up for science-based care

April 19, 2017  |  Gary A. Enos, Editor
article
Newt Gingrich and Patrick Kennedy have at least one thing in common: an absolute reverence for brain research that can inform solutions to the opioid crisis.

Rx Summit: Speakers from Congress differ on recipe for opioid crisis

April 18, 2017  |  Gary A. Enos, Editor
article
A congressional forum at the National Rx Drug Abuse & Heroin Summit had one member saying the nation can't throw money at the crisis, while another warned of dangerous directions from the nominated FDA leader.

General health clinics, specialty care will go head-to-head in opioid treatment study

April 14, 2017  |  Gary A. Enos, Editor
article
An 800-patient Treatment Research Institute (TRI) study will test whether a general health sector that created much of the opioid misuse crisis can help to solve it.

Could a device attached to the ear become a game-changer in detox?

April 12, 2017  |  Gary A. Enos, Editor
article
An electrical stimulation device that is approved for pain is gaining use as a method of easing withdrawal from opioids and facilitating access to longer-term treatment.

Harvard course on opioids has relevance for professionals, public

April 7, 2017  |  Gary A. Enos, Editor
article
As part of its public health mission, Harvard Medical School's Harvard Health Publications has introduced a self-guided opioid course that is proving popular among treatment professionals and the public.

Ohio enacts limits on prescribing for acute pain

April 4, 2017  |  Gary A. Enos, Editor
news
New regulations on opioid prescribing in Ohio arrive at a time when some lawmakers are advocating even stricter limits.

Brightside Clinic hires medical director

March 20, 2017  |  Gary A. Enos, Editor
news
David Kushner, DO, FACP, has been named medical director at Brightside Clinic, the buprenorphine treatment organization with offices in two Illinois communities.

Report: Risk of long-term opioid use increases in initial week of treatment

March 17, 2017  |  Gary A. Enos, Editor
article
Data released this week by the Centers for Disease Control and Prevention (CDC) make a case for significant limits on initial prescriptions of opioids.

Pages

Subscribe to Medication